| Dr Shin Ogita, MD | |
|
4100 John R St, Hw04ho, Detroit, MI 48201-2013 | |
| (313) 576-8740 | |
| (313) 576-8381 |
| Full Name | Dr Shin Ogita |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 4100 John R St, Detroit, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265679088 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301091769 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shin Ogita, MD 4100 John R St, Hw04ho, Detroit, MI 48201-2013 Ph: (313) 576-8740 | Dr Shin Ogita, MD 4100 John R St, Hw04ho, Detroit, MI 48201-2013 Ph: (313) 576-8740 |
News Archive
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it submitted to the FDA a pre IND package on Zertane, its on-demand premature ejaculation drug, for a meeting and discussion on the approval path under the 505(b) 2 regulation/registration requirement in the US.
A common prostate cancer therapy should not be used in men whose cancer has not spread beyond the prostate, according to a new study led by researchers at Henry Ford Hospital.
Fructose, the sugar widely used as high-fructose corn syrup in soft drinks and processed foods, often gets some of the blame for the widespread rise in obesity. Now a laboratory study has found that when fructose is present as children's fat cells mature, it makes more of these cells mature into fat cells in belly fat and less able to respond to insulin in both belly fat and fat located below the skin.
The Food and Drug Administration's recent approval of the drug olaparib for ovarian cancer patients with inherited mutations in the genes BRCA1 or BRCA2 came as welcome news to the thousands of women now eligible to receive it. A new study by Dana-Farber Cancer Institute scientists indicates that the pool of patients who can benefit from the drug is potentially much wider - and offers a ready means of identifying them.
Fitch Ratings has upgraded its long-term rating to 'BBB+' from 'BBB-' on $14 million of the Albany Industrial Development Agency civic facility revenue bonds (Albany College of Pharmacy Project). The Rating Outlook is Stable.
› Verified 4 days ago
Dr. Saba Alan Francis, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 50 E Canfield St, Detroit, MI 48201 Phone: 313-745-4525 | |
Dr. Roopkiranjot Kahlon, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4201 Saint Antoine St, University Health Center 2e, Detroit, MI 48201 Phone: 313-745-4525 | |
Avi Cohen, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Waleed Obaid, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6071 W Outer Dr, Detroit, MI 48235 Phone: 313-966-3250 | |
Lindsey Aurora, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Alexander Garbarino, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Maria Diab, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 800-653-6568 Fax: 313-876-1305 |